Bausch + Lomb Announces Results from First Phase 3 Trial of NOV03

Bausch + Lomb and Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, announced statistically significant...

Read More
Fighting Blindness Canada research

Gene Therapy Approach to Regenerate Damaged Optic Nerves

Scientists from the University of Cambridge have used gene therapy to regenerate damaged optic nerves in the eyes of mice, offering hope that this...

Read More
Fighting Blindness Canada

Using CRISPR to Treat Glaucoma

Researchers from the University of Bristol that are looking for a more long-term treatment option for open angle glaucoma, have turned to gene...

Read More
Fighting Blindness Canada

CRISPR: Making the Cut to Restore Vision

CRISPR (also known as CRISPR-Cas9) is a gene editing technique that allows scientists to cut DNA very precisely It’s like a pair of molecular...

Read More
Fighting Blindness Canada logo

LHON Study Finds Double the Impact

In a surprising finding, scientists have shown that injecting a gene therapy for Leber’s Hereditary Optic Neuropathy (LHON) into one eye can...

Read More
1 13 14 15 16 17 51